Skip to content

Comparison of two fluid therapy methods during hepatectomy

Comparison of two fluid therapy methods during hepatectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052109
Enrollment
Unknown
Registered
2021-10-17
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatectomy

Interventions

Experimental group1:Control the central venous pressure
Experimental group2:Target directed infusion

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective hepatectomy; 2. Informed consent of the patient and voluntary participation;

Exclusion criteria

Exclusion criteria: 1. Severe obesity; 2. Patients with uncontrolled hypertension before surgery; 3. Serious comorbidities of other systems; 4. ASA classification is greater than grade III; 5. Patients whose CVP or SVV is not within the set range for more than 5 minutes; 6. Patients with major bleeding during surgery or patients who need to be admitted to ICU for further treatment after surgery.

Design outcomes

Primary

MeasureTime frame
blood loss;

Secondary

MeasureTime frame
duration of surgery;number of patients requiring transfusion;transfusion volume;

Countries

China

Contacts

Public ContactShen Qihong

The First Hospital of Jiaxing

shenqihong1989@163.com+86 15088554023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026